PH30691A - Pharmaceutical composition for increasing bladder capacity. - Google Patents
Pharmaceutical composition for increasing bladder capacity.Info
- Publication number
- PH30691A PH30691A PH45387A PH45387A PH30691A PH 30691 A PH30691 A PH 30691A PH 45387 A PH45387 A PH 45387A PH 45387 A PH45387 A PH 45387A PH 30691 A PH30691 A PH 30691A
- Authority
- PH
- Philippines
- Prior art keywords
- denotes
- carbon atoms
- alkyl group
- group
- dysuria
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 206010013990 dysuria Diseases 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000027939 micturition Effects 0.000 abstract 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 1
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3325458A JP2549480B2 (ja) | 1991-12-10 | 1991-12-10 | 排尿障害改善剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH30691A true PH30691A (en) | 1997-09-16 |
Family
ID=18177097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH45387A PH30691A (en) | 1991-12-10 | 1992-12-09 | Pharmaceutical composition for increasing bladder capacity. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5496823A (cs) |
| EP (1) | EP0546547B1 (cs) |
| JP (1) | JP2549480B2 (cs) |
| KR (1) | KR930012019A (cs) |
| CN (1) | CN1073861A (cs) |
| AT (1) | ATE110569T1 (cs) |
| AU (1) | AU656443B2 (cs) |
| CA (1) | CA2084962A1 (cs) |
| CZ (1) | CZ282422B6 (cs) |
| DE (1) | DE69200365T2 (cs) |
| DK (1) | DK0546547T3 (cs) |
| ES (1) | ES2062860T3 (cs) |
| HU (2) | HUT63055A (cs) |
| IL (1) | IL104026A (cs) |
| MX (1) | MX9207123A (cs) |
| PH (1) | PH30691A (cs) |
| TW (1) | TW210286B (cs) |
| ZA (1) | ZA929529B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5780476A (en) * | 1992-11-16 | 1998-07-14 | Cell Therapeutics, Inc. | Hydroxyl-containing xanthine compounds |
| DE19529102A1 (de) * | 1995-08-08 | 1997-02-13 | Kummer Horst Dieter | Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen |
| CA2266070A1 (en) * | 1996-09-19 | 1998-03-26 | American Home Products Corporation | Method of treating urinary incontinence |
| WO2020186187A1 (en) * | 2019-03-13 | 2020-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for treating bladder and urethra dysfunction and disease |
| BR112022004441A2 (pt) | 2019-10-02 | 2022-06-07 | Aska Pharm Co Ltd | Agente para melhorar distúrbio de micção |
| WO2021065027A1 (ja) | 2019-10-02 | 2021-04-08 | あすか製薬株式会社 | 排尿障害改善剤 |
| WO2022131354A1 (ja) | 2020-12-18 | 2022-06-23 | あすか製薬株式会社 | 固形製剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| JP2661666B2 (ja) * | 1988-02-19 | 1997-10-08 | ヘキスト薬品工業株式会社 | 抗消化性潰瘍剤 |
-
1991
- 1991-12-10 JP JP3325458A patent/JP2549480B2/ja not_active Expired - Lifetime
-
1992
- 1992-12-08 KR KR1019920023551A patent/KR930012019A/ko not_active Abandoned
- 1992-12-08 IL IL10402692A patent/IL104026A/en not_active IP Right Cessation
- 1992-12-09 AU AU29985/92A patent/AU656443B2/en not_active Ceased
- 1992-12-09 ZA ZA929529A patent/ZA929529B/xx unknown
- 1992-12-09 MX MX9207123A patent/MX9207123A/es not_active IP Right Cessation
- 1992-12-09 PH PH45387A patent/PH30691A/en unknown
- 1992-12-09 CA CA002084962A patent/CA2084962A1/en not_active Abandoned
- 1992-12-09 CZ CS923611A patent/CZ282422B6/cs unknown
- 1992-12-10 HU HU9203911A patent/HUT63055A/hu unknown
- 1992-12-10 EP EP92121075A patent/EP0546547B1/en not_active Expired - Lifetime
- 1992-12-10 DE DE69200365T patent/DE69200365T2/de not_active Expired - Fee Related
- 1992-12-10 DK DK92121075.3T patent/DK0546547T3/da active
- 1992-12-10 TW TW081109882A patent/TW210286B/zh active
- 1992-12-10 CN CN92114111A patent/CN1073861A/zh active Pending
- 1992-12-10 AT AT92121075T patent/ATE110569T1/de not_active IP Right Cessation
- 1992-12-10 HU HU9203911A patent/HU9203911D0/hu unknown
- 1992-12-10 ES ES92121075T patent/ES2062860T3/es not_active Expired - Lifetime
-
1994
- 1994-08-09 US US08/287,794 patent/US5496823A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5496823A (en) | 1996-03-05 |
| MX9207123A (es) | 1993-07-30 |
| IL104026A (en) | 1995-11-27 |
| JP2549480B2 (ja) | 1996-10-30 |
| AU2998592A (en) | 1993-06-17 |
| AU656443B2 (en) | 1995-02-02 |
| DE69200365D1 (de) | 1994-10-06 |
| JPH05155773A (ja) | 1993-06-22 |
| CA2084962A1 (en) | 1993-06-11 |
| HU9203911D0 (en) | 1993-03-29 |
| TW210286B (cs) | 1993-08-01 |
| DK0546547T3 (da) | 1995-02-13 |
| CZ361192A3 (en) | 1993-09-15 |
| KR930012019A (ko) | 1993-07-20 |
| CN1073861A (zh) | 1993-07-07 |
| EP0546547B1 (en) | 1994-08-31 |
| HUT63055A (en) | 1993-07-28 |
| EP0546547A1 (en) | 1993-06-16 |
| IL104026A0 (en) | 1993-05-13 |
| ES2062860T3 (es) | 1994-12-16 |
| CZ282422B6 (cs) | 1997-07-16 |
| DE69200365T2 (de) | 1995-02-16 |
| ATE110569T1 (de) | 1994-09-15 |
| ZA929529B (en) | 1993-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3029603T3 (en) | Cytotoxic stilbene derivatives and pharmaceutical composition containing them. | |
| HK85984A (en) | Nasal pharmaceutical compositions | |
| GB8804058D0 (en) | 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds | |
| CA2029420A1 (en) | Pharmaceutical compositions and methods for inhibition of maillard's reaction | |
| IE800327L (en) | N-substituted aziridine-2-carboxylic acid derivatives | |
| TW261616B (cs) | ||
| ES8200011A1 (es) | Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. | |
| EP0682009A3 (en) | Intermediate compounds for the preparation of endothelin receptor antagonist triterpene derivatives. | |
| PH30691A (en) | Pharmaceutical composition for increasing bladder capacity. | |
| AU1959192A (en) | The use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas | |
| CA2220024A1 (en) | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | |
| IL105558A0 (en) | Therapeutic alcohols | |
| IL110894A0 (en) | Cephem derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| EP0014981A3 (en) | Medicaments and pharmaceutical compositions with cytostatic activity | |
| AU2224795A (en) | Ameliorant or remedy for paraneoplastic syndrome | |
| TW360630B (en) | A secoaporphine compounds on arrhythmia | |
| RU92004490A (ru) | Фармацевтическая композиция для лечения дизурии и способ ее лечения |